Shree Ganesh Remedies Ltd
BSE:540737
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
|
Shree Ganesh Remedies Ltd
BSE:540737
|
5.9B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
997.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.5B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.1B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Shree Ganesh Remedies Ltd
Glance View
Shree Ganesh Remedies Ltd. engages in the research, development, manufacture, and marketing of healthcare products. The company is headquartered in Ankleshwar, Gujarat. The company went IPO on 2017-10-13. The firm is a supplier of pharmaceutical intermediates and specialty chemicals with chlorination, grignard reaction, hydrogenation and high-vacuum distillation. Its products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. The company offers services, including customized chemistry and manufacturing, assets and infrastructure and key technologies and expertise. The company also delivers service of contract manufacturing for chemical reactions like amination, amidation, alkylation, bromination, catalytic hydrogenation and chlorination. The firm's subsidiaries include Akshar Jyot Private Limited and Dhari Chemicals Limited.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Shree Ganesh Remedies Ltd is 18%, which is below its 3-year median of 20.5%.
Over the last 3 years, Shree Ganesh Remedies Ltd’s Net Margin has decreased from 18.4% to 18%. During this period, it reached a low of 18% on Jan 1, 2026 and a high of 23.3% on Dec 31, 2024.
